Paul Frohna

Paul Frohna, MD, PhD, is an accomplished medical professional with extensive experience in clinical development and research leadership across various biotech companies. Currently serving as a Scientific and Clinical Advisory Board Member at IAMA Therapeutics and a member of the Board of Directors at Accure Therapeutics, Paul Frohna has also held senior roles such as Chief Medical Officer at Endeavor Biomedicines and Imcheck Therapeutics, where responsibilities included overseeing all R&D activities and leading successful fundraising efforts. Previous positions include Chief Medical Officer at Bioniz Therapeutics, Product Development Leader for the CIRM Grant Team at Cedars Sinai, and Vice President of Clinical Development at both Receptos and FibroGen. Educational credentials encompass a Pharmacy Degree from The University of Texas at Austin, an MD from Georgetown University, and a PhD in Pharmacology from the University of Pennsylvania.